000186847 000__ 01520fam\a2200361\a\4500
000186847 001__ 186847
000186847 005__ 20220217103707.0
000186847 008__ 961216s1996\\\\dcua\\\\\b\\\f000\0\eng\d
000186847 020__ $$a0160537118
000186847 035__ $$a(OCoLC)ocm36094827
000186847 035__ $$9(IS)TVY8456
000186847 035__ $$9AAV5657SI
000186847 035__ $$a186847
000186847 040__ $$aGPO$$cGPO
000186847 043__ $$an-us---
000186847 049__ $$aISUW
000186847 074__ $$a1019-A-01
000186847 0860_ $$aY 4.C 73/8:104-113
000186847 088__ $$aSerial no. 104-113 (United States. Congress. House. Committee on  Commerce)
000186847 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Commerce.$$bSubcommittee on Oversight and Investigations.
000186847 24510 $$aPerspectives on pharmaceutical pricing practices :$$bhearing       before the Subcommittee on Oversight and Investigations of the Committee on     Commerce, House of Representatives, One Hundred Fourth Congress, second session, September 19, 1996.
000186847 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,$$c1996.
000186847 300__ $$aiii, 69 p. :$$bill. ;$$c23 cm.
000186847 500__ $$aDistributed to some depository libraries in microfiche.
000186847 500__ $$aShipping list no.: 97-0072-P.
000186847 500__ $$a"Serial no. 104-113."
000186847 504__ $$aIncludes bibliographical references.
000186847 650_0 $$aPharmacy$$zUnited States.
000186847 650_0 $$aPrescription pricing$$zUnited States.
000186847 650_0 $$aConsumer protection$$zUnited States.
000186847 650_0 $$aPharmaceutical industry$$zUnited States.
000186847 650_0 $$aPrice fixing$$zUnited States.
000186847 85230 $$bdfich$$hY 4.C 73/8:$$i104-113
000186847 909CO $$ooai:library.usi.edu:186847$$pGLOBAL_SET
000186847 948__ $$ac:jb
000186847 980__ $$aBIB
000186847 980__ $$aGOV RESOURCE